
How a Texas healthcare company cracked the code on rising employer healthcare costs
Next Level, the name behind Texas' ubiquitous urgent care clinics, isn't just in the business of treating colds and sprains. With just over 800 employees of its own, the company faced the same challenge plaguing businesses across the country: how to offer meaningful, accessible healthcare benefits without going bankrupt.
'Claims were up 30 percent year over year, and pharmacy spend was climbing faster than ever,' said Juliet Breeze, MD, CEO and Founder of Next Level. 'Like everyone else, we were staring down a future where doing right by our people meant unsustainable costs.'
But rather than pass the cost on to employees or trim benefits, Breeze and her team decided to rethink the model altogether. The result was Next Level Prime, a healthcare benefits program built on the principles of direct primary care (DPC), layered with wraparound services aimed at improving access, reducing chronic disease risk, and lowering total cost of care.
What started as an internal solution for Next Level's workforce has since become a fast-growing option for other Texas employers looking for a better way. In 2024 alone, organizations using Next Level Prime saved a combined $26 million in healthcare claims, proof that a more proactive, prevention-first model doesn't just sound good – it works.
A Smarter Front Door to Healthcare
At the core of Next Level Prime is the belief that early, convenient access to care changes everything. Rather than waiting until health issues spiral into costly emergencies, members can walk into any Next Level clinic (open 9 a.m. to 9 p.m., seven days a week), access telemedicine 24/7, and receive care that emphasizes prevention and chronic disease management.
One of the biggest impacts? Emergency room avoidance. In 2024, over 7,100 Prime members reported that without access to the program, they would have sought care at the ER. Those avoided visits alone accounted for $19.5 million of the total savings.
'The best way to save money on healthcare is to keep people healthy and out of hospitals in the first place,' said Breeze.
That philosophy extends beyond urgent care and into proactive, lifestyle-based interventions. Recognizing that obesity is a key contributor to chronic conditions like diabetes and heart disease, Next Level integrated a comprehensive weight management program into its Prime offering. The program includes personalized coaching, regular monitoring, and access to effective, affordable medications for eligible members. While nationally about 33% of health plan members now use high-cost, brand-name medications for weight loss and diabetes, fewer than 1% Next Level's health plan members do. It's not because they're going without care, but because they're using Next Level's in-house alternative instead. At an employer cost of just $189 per month, the program delivers the same therapeutic benefit at a fraction of the typical $1,140 monthly cost of brand-name drugs. Employers avoid skyrocketing pharmacy bills, and employees get meaningful support without the co-pay.
A Growing Community of Savvy Employers
Next Level isn't alone in its desire to fix a broken system. As more employers push their benefits consultants to explore nontraditional options, word about Next Level Prime is spreading. Today, the program serves more than 360 employers and boasts a 97% retention rate.
'Employers are done accepting the status quo,' said Breeze. 'They're asking tougher questions. They want to know what else is out there, and they want solutions that are proven, not just theoretical.'
Next Level works both directly with employers as well as through brokers, making it easy to customize the program based on each company's needs. The goal is to ensure employers have access to innovative solutions like Prime, whether they come through a trusted advisor or explore it on their own.
More Than a Benefit—A Retention Tool
The ripple effects of Prime go beyond dollars and cents. Healthier employees are less likely to miss work, more likely to stay with their employers, and more engaged when they're on the job. With a Net Promoter Score (NPS) over 90, the program is proving to be as popular with employees as it is with finance teams.
'When healthcare is easy to access, judgment-free, and actually helps people feel better, it changes everything,' said Breeze.
And in an era of rising healthcare costs and growing burnout, that kind of change isn't just welcome, it's essential.
Click here to learn more about Next Level Prime.
Next Level is a physician-founded healthcare organization providing high-quality, affordable care across more than 45 clinics throughout Austin, Houston, San Antonio, and Beaumont. Open daily from 9 a.m. to 9 p.m., Next Level is committed to transforming the healthcare experience through speed, convenience, and compassion. In addition to urgent and primary care services, the organization partners with employers through its innovative Next Level PRIME program, a direct primary care and urgent care solution that offers employees and their families unlimited in-clinic and virtual visits with no copays or deductibles. Employers benefit from significant reductions in emergency room visits, increased productivity, and improved staff retention. Next Level also provides customized onsite clinics and occupational medicine programs designed to streamline workplace injury care and enhance overall employee health. As a trusted healthcare partner for businesses, schools, and municipalities, Next Level Urgent Care continues to set the standard for accessible, value-driven medical care in Texas.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Boston Globe
21 minutes ago
- Boston Globe
Gates Foundation money fills gap in women's health
McKinsey Advertisement That's why the Gates Foundation's announcement of $2.5 billion in investments through 2030 for women's health — Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up The investment will fund research and development in maternal and obstetrical care to make pregnancy and childbirth safer, gynecological care and menstrual health, contraception, nutrition, and treatment of sexually transmitted infections. The Gates Foundation has a history of investing in areas that don't draw market-based or government funding. Its goal is to turn basic scientific research into cost-effective products that can be sold worldwide, particularly in lower-income countries. For example, at the STAT event, foundation founder Bill Gates showed off a plastic drape attached to a container with measuring marks that can be placed on the table where a woman is giving birth and used to measure blood loss. Postpartum hemorrhage can kill birthing women, and Gates said the $1 item can help health care providers identify dangerous blood loss, so treatment can be given sooner. Advertisement On the other end of the technological spectrum, Gates highlighted an artificial intelligence-powered ultrasound, currently being tested by Philips, that can send information to a health worker's cellphone about whether a pregnancy is high-risk. The goal is to make it easier for midwives in areas without ultrasound technicians to take an ultrasound, interpret the results, and send women with high-risk pregnancies for more advanced care. The good news for Massachusetts is the state's strong biotech ecosystem means some ideas funded by the Gates Foundation will be researched and developed here. For example, Giovanni Traverso, director of the Laboratory for Translational Engineering at MIT, received money to develop a transdermal patch that could provide women with long-term contraception. The lab is also developing probiotic medications to treat abnormalities in the vaginal microbiome, a condition associated with risks including painful infection and premature birth. Traverso said the foundation invests in high-risk, early-stage research that few commercial investors will back, then focuses on developing cost-effective products. 'The foundation again and again has been willing to take risks recognizing many things we do don't work. But if a few do, they could have a big impact,' Traverso said. Scott Johnson, CEO of Concord-based Comanche Biopharma, is trying to develop the first drug to treat preeclampsia (high blood pressure during pregnancy). If the drug is approved, Johnson said the Gates Foundation will help distribute it in low-income countries. The foundation gave Comanche Biopharma money to improve the chemical manufacturing process and package the drug in a prefilled syringe, making it cheaper and simpler to deliver. Advertisement Johnson hopes after initial trials in wealthier countries, Gates Foundation funding and expertise will help the company do clinical trials in Ghana, Kenya, and South Africa, with an eye toward getting the drug approved and distributed in areas where sales wouldn't otherwise be economically viable. Other Massachusetts grantees include researchers at Beth Israel Lahey Health, Mass General Brigham, Boston Children's Hospital, Harvard University, Fenway Health, Tufts University, and UMass Chan Medical School. Rasa Izadnegahdar, director of maternal, newborn, child nutrition and health for the Gates Foundation, said the goal is to catalyze private-sector investment in an area of health research with global applicability that has never had sustained funding. 'It's a high return-on-investment area,' Izadnegahdar said. 'That could be economic, societal, or from the lens of survival, including in low- and middle-income country settings. When you invest in improving the life of a woman, you're substantially increasing the opportunity of survival for her children, and it has an impact on the community.' Especially as the federal government cuts support for scientific research, Gates's investment highlights the good that can be done by private philanthropy filling the gap. Editorials represent the views of the Boston Globe Editorial Board. Follow us
Yahoo
38 minutes ago
- Yahoo
Nigerian profitable food delivery Chowdeck lands $9M from Novastar, Y Combinator
Chowdeck, a Lagos-based food delivery startup that has stayed profitable in a notoriously tough and low-margin market, has raised $9 million in Series A funding to launch a quick commerce strategy and expand into more cities in Nigeria and Ghana. The equity round was led by Novastar Ventures, with participation from Y Combinator, AAIC Investment, Rebel Fund, GFR Fund, Kaleo, HoaQ, and others. The investors are betting on the team's ability to pair local market expertise with execution and turn a notoriously difficult sector into a profitable super app for food, groceries and essentials. 'We're thrilled about this round as it brings us closer to our vision of becoming Africa's number one super app,' CEO and co-founder Femi Aluko said. 'This funding will supercharge our growth plans, enabling us to expand into more cities, reduce delivery times, scale our grocery footprint, and attract the best talent to drive innovation and customer satisfaction.' Founded in October 2021 by Aluko, Olumide Ojo, and Lanre Yusuf, Chowdeck now operates in 11 cities across Nigeria and Ghana, serving 1.5 million customers with a network of more than 20,000 riders. Its logistics system averages 30 minutes per order, and in dense areas, more than half of deliveries arrive by bicycle. While prominent players have exited or scaled back their African operations, Chowdeck has leaned into the complexity of local markets—delivering local meals, an operationally harder challenge—to build trust with customers. In 2024, the value of meals delivered through Chowdeck grew more than sixfold from the previous year. This year, the company says it passed its 2024 total before July. The new funding will help Chowdeck roll out quick commerce, ultra-fast delivery backed by a network of dark stores and hyperlocal logistics hubs. The company plans to open 40 dark stores by the end of this year and 500 by the end of 2026, with two to three new stores launching each week. Chowdeck raised a $2.5 million seed round last year. Food delivery is a crowded business globally, but when done well, it has led to some other big companies like DoorDash. Quick commerce, on the other hand, has been a capital-intensive gamble in most markets. In Europe, Gorillas and Getir burned through hundreds of millions of dollars before retreating or consolidating. In India, platforms like Blinkit, Zepto and Swiggy have had varying levels of success with the model when it comes to profitability. Chowdeck has been profitable since before this raise and Aluko says the company doesn't enter cities or verticals without planning to break even within a couple of weeks. For instance, the food delivery platform entered neighbouring Ghana this May. Within three months, it was handling 1,000 daily orders without paid advertising, which, according to Aluko, came from pent-up demand for a service that delivers local favorites alongside international cuisines. The company aims to quintuple that volume to 5,000 daily orders by the end of September 2025. Aluko says Chowdeck plans to apply the same playbook to dark stores, which will complement its restaurant and grocery delivery operations. Another vertical complementing these operations will be software. This June, the YC-backed startup acquired Mira, a point-of-sale provider for African food and hospitality businesses. Mira's tools manage inventory and orders in real time; now, it will help Chowdeck optimize its operations, positioning the company as a vertical SaaS-plus-logistics provider for restaurants. Chowdeck's raise is a win for local players in the sector, after Jumia's exit left market share to foreign brands such as Glovo, Bolt Food, and Yango. Yet, some of these companies have also withdrawn from certain markets, including Nigeria and Ghana, which Chowdeck is now targeting aggressively. Super apps such as Gozem, YC-backed Yassir, and MNT-Halan are other local companies offering food delivery services in other African markets. 'The market is still very early,' Aluko said. 'Customer behavior is shifting online for the first time. A whole generation is growing up ordering food without ever having walked into some of the restaurants or markets on our platform.' For lead investor Novastar Ventures, the bet is on execution and local insight. 'Chowdeck is building the future of logistics for African cities,' said partner Brian Waswani Odhiambo. 'With deep local insight, a sustainability-first approach, and impressive execution, it is redefining last-mile delivery on the continent.' Nigeria's YC-backed Chowdeck hopes to scale food delivery, a notoriously tough market, with $2.5M funding Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNBC
an hour ago
- CNBC
Elon Musk's Tesla launches bid to supply electricity to British households
Elon Musk's electric vehicle manufacturer and energy company Tesla is preparing to supply electricity to British households and businesses. The Texas-based company formally submitted its request for an electricity license to the British energy regulator Ofgem at the end of last month, according to a notice on the watchdog's website. If approved, the move could pave the way for Tesla to compete with the big firms that dominate the U.K. energy market from as soon as next year. The application, first reported by the Sunday Telegraph, came from Tesla Energy Ventures and was signed by Andrew Payne, who runs the firm's European energy operations. Tesla, which is best known as one of the world's leading EV manufacturers, also develops solar energy generation systems and battery energy storage products. Musk's company already has an electricity supplier in Texas, called Tesla Electric. The service, which was launched in 2022, allows customers to optimize energy consumption and pays them for selling excess energy back to the grid. Tesla's push for a license to supply electricity to British households comes as the company endures a protracted European sales slump. Data published last week by the U.K.'s Society of Motor Manufacturers and Traders (SMMT) showed Tesla's new car sales dropped by nearly 60% to 987 units last month, down from 2,462 a year ago. In Germany, meanwhile, Tesla car sales fell to 1,110 units in July, down 55.1% from the same month in 2024. The latest sales figures underscored some of the challenges facing the company, which continues to face stiff competition, particularly from Chinese EV manufacturers, and reputational damage from Musk's incendiary rhetoric and relationship with U.S. President Donald Trump's administration.